609 articles
A 12-week Brazilian trial tests whether training frequency shapes functional capacity and blood pressure in older adults with cardiometabolic risk.
A Canadian RCT tests whether virtual aerobic, resistance, and cognitive training can feasibly combat mild cognitive impairment at home.
The CLEAR Harmony trial tested bempedoic acid's safety in statin-intolerant patients with uncontrolled LDL and high cardiovascular risk.
A completed clinical trial tests which dietary approach best controls extreme triglyceride levels in multifactorial chylomicronemia patients.
Phase 3 trial pits next-gen GnRH antagonist degarelix against standard goserelin in prostate cancer hormone suppression.
A pilot RCT tests whether the SysLife© app can reduce subjective stress and improve functioning in work and personal life.
A completed phase 2 trial tested nab-paclitaxel combined with the checkpoint inhibitor pembrolizumab in patients with advanced urothelial cancer who cannot tolerate cisplatin.
A completed Montreal trial tested remote physical and cognitive training in 122 older adults with cardiovascular disease.
A phase II trial tests whether 1Gy intestinal radiation can re-sensitize solid tumors that have stopped responding to immunotherapy.
A completed University of Florida trial probes why aerobic exercise improves artery function in older men but yields inconsistent results in postmenopausal women.
A Phase 2 trial examines whether adding the anti-angiogenic drug bevacizumab to standard chemo improves outcomes in pediatric sarcoma.
A completed longitudinal study tracks brain structure, function, and behavior in healthy infants across the first year of life.
